Patent · US Active

Short-acting Factor VII polypeptides

US11530401B2 · kind B2 · utility

0Cited by

7References

22Claims

0Family size

Assignee

Coagulant Therapeutics Corporation · KR

Inventors

Maxine Bauzon · Hercules, US
Terry Hermiston · Corte Madera, US

Key dates

Filing date	Jun 9, 2020
Grant date	Dec 20, 2022
Priority date	—
Expiry date	Sep 22, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Short-acting Factor VII peptides are disclosed. A shortened half-life is desirable for treatment of acute bleeding and similar disorders. Modification of the sialylation and/or glycosylation of Factor VII and variants thereof produced peptides useful in treating conditions of acute bleeding.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.